Related Experiment Videos
Persistent parathyroid hormone elevation following curative parathyroidectomy for primary hyperparathyroidism
Elizabeth A Mittendorf1, Christopher R McHenry
1Department of Surgery, MetroHealth Medical Center, 2500 MetroHealth Dr, H920, Cleveland, OH 44109-1998, USA.
Archives of Otolaryngology--Head & Neck Surgery
|March 12, 2002
Summary
Persistent high parathyroid hormone (PTH) levels after parathyroidectomy are common (27%) and usually temporary. Musculoskeletal symptoms and black race are risk factors, but this elevation often resolves, likely due to bone remineralization.
Area of Science:
- Endocrinology
- Surgical Oncology
- Neurosurgery
Background:
- Persistent elevation of parathyroid hormone (PTH) after parathyroidectomy may suggest residual abnormal parathyroid tissue.
- Understanding the clinical significance and risk factors for this elevation is crucial for patient management.
Purpose of the Study:
- To determine the clinical significance of persistent PTH elevation post-parathyroidectomy.
- To identify risk factors associated with elevated PTH levels following curative parathyroidectomy for primary hyperparathyroidism.
Main Methods:
- A prospective study monitored 85 patients with resolved hypercalcemia post-parathyroidectomy.
- Serial calcium and PTH levels were analyzed, with multivariate analysis identifying associated features.
- Patients with persistent PTH elevation were compared to those with normal levels.
Main Results:
- 27% of patients (23/85) exhibited elevated postoperative PTH levels.
- Black race and musculoskeletal symptoms were significantly associated with persistent PTH elevation (P=.01).
- In most cases, PTH levels normalized or decreased within 16 months, suggesting a transient phenomenon.
Conclusions:
- Persistent PTH elevation post-parathyroidectomy occurs in 27% of patients and is typically transient.
- This elevation is more common in patients with musculoskeletal symptoms and of black race.
- It is likely a secondary response to bone remineralization, not indicative of persistent disease.